A Study to Evaluate Subcutaneous Durvalumab in Patients With Non-Small Cell Lung Cancer and Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Durvalumab
Related studies linked through entity extraction aliases.
A Study to Compare Ociperlimab Plus Tislelizumab Versus Durvalumab Following Concurrent Chemoradiotherapy (cCRT) in Participants With Stage III Unresectable Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Radiotherapy Plus Durvalumab in Elderly Esophageal Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- NA
TremelImumab aNd Durvalumab For the Non-operatIve Management (NOM) of MSI-high Resectable GC/GEJC.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
The Purpose of This Trial is to Determine if Regorafenib Plus Durvalumab (MEDI4736) is Safe and Effective in Treatment of Chemo Refractory Advanced Biliary Tract Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of Durvalumab in Combination With Platinum and Etoposide for the First Line Treatment of Patients With Extensive-stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Durvalumab and Chemotherapy Induction Followed by Durvalumab and Radiotherapy in Large Volume Stage III NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
Study of AZD2811 + Durvalumab in ES-SCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Durvalumab Plus Chemotherapy in Untreated Patients With Extensive-Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Combining Epigenetic And Immune Therapy to Beat Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
- Status
- RECRUITING
- Phase
- PHASE1
A Real-world Study of Durvalumab for Lung Cancer in China
- Status
- UNKNOWN
- Phase
- N/A
Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Observational Study of Durvalumab in Patients With Non-small-cell Lung Cancer in the United Kingdom
- Status
- COMPLETED
- Phase
- N/A